Centre for Drug Design & Discovery (CD3)
CD3 is a drug discovery center and investment fund based in Leuven, Belgium, focusing on transforming innovative biomedical research into new medicines. It collaborates with academic institutes and biotech/pharma partners, providing expertise, infrastructure, and funding to develop potential new drugs. Its mission is to discover medicines that address serious medical needs through partnerships, investments, and co-creation of new drugs.
Industries
Nr. of Employees
small (1-50)
Centre for Drug Design & Discovery (CD3)
Products
RSV antivirals
Project developing antiviral molecules targeting respiratory syncytial virus (RSV).
Dengue virus inhibitors
Project focused on discovery of inhibitors active against dengue virus.
Yap/TAZ-TEAD inhibitors
Project developing inhibitors targeting the Yap/TAZ-TEAD pathway for hippo-dependent cancers.
MALT1 inhibitors
Project focused on discovery of MALT1 inhibitors for autoimmune and inflammatory diseases.
Influenza virus inhibitors
Project developing inhibitor molecules active against influenza viruses.
HRV (human rhinovirus) inhibitors
Project focused on discovery of inhibitors targeting human rhinovirus.
RSV antivirals
Project developing antiviral molecules targeting respiratory syncytial virus (RSV).
Dengue virus inhibitors
Project focused on discovery of inhibitors active against dengue virus.
Yap/TAZ-TEAD inhibitors
Project developing inhibitors targeting the Yap/TAZ-TEAD pathway for hippo-dependent cancers.
MALT1 inhibitors
Project focused on discovery of MALT1 inhibitors for autoimmune and inflammatory diseases.
Influenza virus inhibitors
Project developing inhibitor molecules active against influenza viruses.
HRV (human rhinovirus) inhibitors
Project focused on discovery of inhibitors targeting human rhinovirus.
Services
Equity investment and co-investment for drug discovery
Provides capital and investment management for drug discovery start-ups, spin-offs and biotech companies and co-invests in collaborative projects.
Co-creation drug discovery collaborations
Project-based collaborations with academic research groups and small companies to jointly discover and advance potential medicines.
High-throughput screening services
Provides HTS workflows and associated automation to identify active compounds against biological targets.
Access to virus bank platform
Access to a viral sample repository to support antiviral research and assay development.
Licensing and partnering support
Facilitates licensing or partnering of discovered molecules to pharmaceutical companies for further development.
Equity investment and co-investment for drug discovery
Provides capital and investment management for drug discovery start-ups, spin-offs and biotech companies and co-invests in collaborative projects.
Co-creation drug discovery collaborations
Project-based collaborations with academic research groups and small companies to jointly discover and advance potential medicines.
High-throughput screening services
Provides HTS workflows and associated automation to identify active compounds against biological targets.
Access to virus bank platform
Access to a viral sample repository to support antiviral research and assay development.
Licensing and partnering support
Facilitates licensing or partnering of discovered molecules to pharmaceutical companies for further development.
Expertise Areas
- Translational drug discovery
- High-throughput screening and hit discovery
- Antiviral drug discovery
- Oncology drug discovery
Key Technologies
- High-throughput screening (HTS)
- Virus biobank / sample repository
- Automated screening robotics
- Assay development for target-based screens